Mutual Advisors’s Boston Scientific BSX Stock Holding History

Mutual Advisors’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$442K	Sell	7,046 -837	-11%	-$67K	0.01%	941
2025 Q4	$752K	Buy	7,883 +620	+9%	+$60.8K	0.02%	695
2025 Q3	$744K	Buy	7,263 +2,887	+66%	+$299K	0.02%	685
2025 Q2	$465K	Sell	4,376 -311	-7%	-$31.5K	0.01%	817
2025 Q1	$478K	Sell	4,687 -2,491	-35%	-$251K	0.01%	731
2024 Q4	$705K	Buy	7,178 +62	+0.9%	+$5.46K	0.02%	594
2024 Q3	$606K	Sell	7,116 -200	-3%	-$15.8K	0.02%	644
2024 Q2	$553K	Buy	7,316 +950	+15%	+$69.5K	0.02%	664
2024 Q1	$436K	Buy	6,366 +367	+6%	+$23.6K	0.01%	737
2023 Q4	$347K	Buy	5,999 +1,029	+21%	+$54.9K	0.01%	774
2023 Q3	$262K	Buy	4,970 +70	+1%	+$3.67K	0.01%	826
2023 Q2	$265K	Buy	+4,900	New	+$256K	0.01%	849

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Mutual Advisors's BSX Position: Q1 2026 in Review

Mutual Advisors reduced its Boston Scientific (BSX) stake by 11% in Q1 2026, selling an estimated $67K and leaving 7,046 shares worth $442K. The position accounts for 0.01% of the portfolio, ranked #941.

Mutual Advisors first reported a position in BSX in Q2 2023 and has held it in 12 quarters since. The position peaked at $752K in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

Mutual Advisors held 7,046 shares of Boston Scientific worth $442K as of Q1 2026.
Mutual Advisors sold 837 Boston Scientific shares in Q1 2026, an estimated $67K.
Boston Scientific made up 0.01% of Mutual Advisors's portfolio in Q1 2026, its #941 holding.
Mutual Advisors first reported a position in Boston Scientific in Q2 2023 and has held it in 12 quarters since.
Mutual Advisors's Boston Scientific position peaked at $752K in Q4 2025.
1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Mutual Advisors's 13F filing for Q1 2026, filed 4 May 2026.